The partnership will use NanoGuardian’s range of overt, covert and forensic anti-counterfeiting measures that can be applied directly to tablets, capsules and vial caps, giving multiple layers of security.
Explaining SDI’s role Dean Hart, executive vice president, NanoGuardian, said: "To ensure the success of Closed-Loop Protection, it was vital to partner with an organisation such as SDI, that has the regulatory experience in conducting proactive market monitoring services and that can manage networks of pharmacies and physicians."
